Document
false--12-31Q120200000842633210000024000000.010.01400000000400000000445626794340955244562679434095520P25YP12YP15YP30YP1YP15YP5YP1YP17Y60000060000025000005000000500000050000000006000006000002500000500000050000005000000P5Y0.010.011000000001000000000000 0000842633 2020-01-01 2020-03-31 0000842633 2019-01-01 2019-03-31 0000842633 2020-04-22 0000842633 2020-03-31 0000842633 2019-12-31 0000842633 2019-03-31 0000842633 2018-12-31 0000842633 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000842633 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000842633 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0000842633 us-gaap:CommonStockMember 2020-03-31 0000842633 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000842633 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000842633 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000842633 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000842633 us-gaap:RetainedEarningsMember 2019-12-31 0000842633 us-gaap:CommonStockMember 2019-12-31 0000842633 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000842633 us-gaap:RetainedEarningsMember 2020-03-31 0000842633 us-gaap:CommonStockMember 2018-12-31 0000842633 us-gaap:RetainedEarningsMember 2018-12-31 0000842633 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000842633 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000842633 us-gaap:CommonStockMember 2019-03-31 0000842633 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000842633 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000842633 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000842633 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000842633 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000842633 us-gaap:RetainedEarningsMember 2019-03-31 0000842633 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember trs:LamonsDivisionMember 2019-12-20 0000842633 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2019-01-01 2019-03-31 0000842633 trs:LamonsDivisionMember 2020-01-01 2020-03-31 0000842633 trs:AerospacecustomerendmarketMember 2020-01-01 2020-03-31 0000842633 trs:AerospacecustomerendmarketMember 2019-01-01 2019-03-31 0000842633 trs:ConsumercustomerendmarketMember 2020-01-01 2020-03-31 0000842633 trs:ConsumercustomerendmarketMember 2019-01-01 2019-03-31 0000842633 trs:IndustrialcustomerendmarketMember 2019-01-01 2019-03-31 0000842633 trs:IndustrialcustomerendmarketMember 2020-01-01 2020-03-31 0000842633 trs:TaplastS.p.A.Member 2018-01-01 2018-12-31 0000842633 trs:RSAEngineeredProductsMemberMember 2020-01-01 2020-03-31 0000842633 trs:PlasticSrlMember 2019-01-01 2019-03-31 0000842633 trs:RSAEngineeredProductsMemberMember 2020-02-27 0000842633 us-gaap:CostOfSalesMember 2019-01-01 2019-03-31 0000842633 trs:PlasticSrlMember 2018-01-01 2018-12-31 0000842633 trs:TaplastS.p.A.Member 2019-04-01 2019-06-30 0000842633 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-03-31 0000842633 trs:RSAEngineeredProductsMemberMember 2019-01-01 2019-12-31 0000842633 trs:RSAEngineeredProductsMemberMember us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0000842633 us-gaap:CustomerRelationshipsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-03-31 0000842633 us-gaap:OtherIntangibleAssetsMember us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0000842633 us-gaap:CustomerRelationshipsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-03-31 0000842633 us-gaap:OtherIntangibleAssetsMember us-gaap:CostOfSalesMember 2019-01-01 2019-03-31 0000842633 trs:AerospaceDefenseReportableSegmentMember 2019-12-31 0000842633 trs:AerospaceDefenseReportableSegmentMember 2020-01-01 2020-03-31 0000842633 trs:PackagingReportableSegmentMember 2019-12-31 0000842633 trs:PackagingReportableSegmentMember 2020-01-01 2020-03-31 0000842633 trs:SpecialtyProductsReportableSegmentMember 2020-03-31 0000842633 trs:SpecialtyProductsReportableSegmentMember 2020-01-01 2020-03-31 0000842633 trs:SpecialtyProductsReportableSegmentMember 2019-12-31 0000842633 trs:PackagingReportableSegmentMember 2020-03-31 0000842633 trs:AerospaceDefenseReportableSegmentMember 2020-03-31 0000842633 trs:MachinedProductsReportingUnitMember 2020-03-31 0000842633 srt:MaximumMember 2020-01-01 2020-03-31 0000842633 us-gaap:CustomerRelationshipsMember 2020-03-31 0000842633 trs:UsefulLifeFifteenToTwentyfiveYearsMember us-gaap:CustomerRelationshipsMember 2019-12-31 0000842633 trs:UsefulLifeSeventeenToThirtyYearsMember us-gaap:OtherIntangibleAssetsMember 2019-12-31 0000842633 us-gaap:TrademarksAndTradeNamesMember 2020-03-31 0000842633 trs:UsefulLifeFifteenToTwentyfiveYearsMember us-gaap:CustomerRelationshipsMember 2020-03-31 0000842633 us-gaap:OtherIntangibleAssetsMember 2019-12-31 0000842633 trs:UsefulLifeFiveToTwelveYearsMember us-gaap:CustomerRelationshipsMember 2020-03-31 0000842633 us-gaap:CustomerRelationshipsMember 2019-12-31 0000842633 trs:UsefulLifeSeventeenToThirtyYearsMember us-gaap:OtherIntangibleAssetsMember 2020-03-31 0000842633 us-gaap:OtherIntangibleAssetsMember 2020-03-31 0000842633 trs:UsefulLifeOneToFifteenYearsMember us-gaap:OtherIntangibleAssetsMember 2020-03-31 0000842633 trs:UsefulLifeFiveToTwelveYearsMember us-gaap:CustomerRelationshipsMember 2019-12-31 0000842633 trs:UsefulLifeOneToFifteenYearsMember us-gaap:OtherIntangibleAssetsMember 2019-12-31 0000842633 us-gaap:TrademarksAndTradeNamesMember 2019-12-31 0000842633 srt:MinimumMember 2020-01-01 2020-03-31 0000842633 srt:MinimumMember trs:UsefulLifeFiveToTwelveYearsMember us-gaap:CustomerRelationshipsMember 2020-01-01 2020-03-31 0000842633 srt:MaximumMember trs:UsefulLifeFifteenToTwentyfiveYearsMember us-gaap:CustomerRelationshipsMember 2020-01-01 2020-03-31 0000842633 srt:MaximumMember trs:UsefulLifeOneToFifteenYearsMember us-gaap:OtherIntangibleAssetsMember 2020-01-01 2020-03-31 0000842633 srt:MinimumMember trs:UsefulLifeOneToFifteenYearsMember us-gaap:OtherIntangibleAssetsMember 2020-01-01 2020-03-31 0000842633 srt:MaximumMember trs:UsefulLifeFiveToTwelveYearsMember us-gaap:CustomerRelationshipsMember 2020-01-01 2020-03-31 0000842633 srt:MaximumMember trs:UsefulLifeSeventeenToThirtyYearsMember us-gaap:OtherIntangibleAssetsMember 2020-01-01 2020-03-31 0000842633 srt:MinimumMember trs:UsefulLifeFifteenToTwentyfiveYearsMember us-gaap:CustomerRelationshipsMember 2020-01-01 2020-03-31 0000842633 srt:MinimumMember trs:UsefulLifeSeventeenToThirtyYearsMember us-gaap:OtherIntangibleAssetsMember 2020-01-01 2020-03-31 0000842633 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:SegmentContinuingOperationsMember 2020-01-01 2020-03-31 0000842633 us-gaap:SegmentContinuingOperationsMember 2020-01-01 2020-03-31 0000842633 us-gaap:CostOfSalesMember us-gaap:SegmentContinuingOperationsMember 2020-01-01 2020-03-31 0000842633 us-gaap:CostOfSalesMember us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-03-31 0000842633 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-03-31 0000842633 us-gaap:SegmentContinuingOperationsMember 2019-01-01 2019-03-31 0000842633 us-gaap:MachineryAndEquipmentMember 2020-03-31 0000842633 us-gaap:BuildingMember 2019-12-31 0000842633 us-gaap:LandAndLandImprovementsMember 2019-12-31 0000842633 us-gaap:BuildingMember 2020-03-31 0000842633 us-gaap:MachineryAndEquipmentMember 2019-12-31 0000842633 us-gaap:LandAndLandImprovementsMember 2020-03-31 0000842633 trs:A4.875SeniorUnsecuredNotesDue2025Member us-gaap:DebtInstrumentRedemptionPeriodFourMember us-gaap:SeniorNotesMember 2020-01-01 2020-03-31 0000842633 trs:A4.875SeniorUnsecuredNotesDue2025Member us-gaap:DebtInstrumentRedemptionPeriodThreeMember us-gaap:SeniorNotesMember 2020-01-01 2020-03-31 0000842633 trs:A4.875SeniorUnsecuredNotesDue2025Member us-gaap:DebtInstrumentRedemptionPeriodTwoMember us-gaap:SeniorNotesMember 2020-01-01 2020-03-31 0000842633 us-gaap:SeniorNotesMember 2020-03-31 0000842633 trs:CreditAgreementMember 2019-12-31 0000842633 us-gaap:SeniorNotesMember 2019-12-31 0000842633 trs:CreditAgreementMember 2020-03-31 0000842633 us-gaap:SeniorNotesMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0000842633 us-gaap:SeniorNotesMember us-gaap:FairValueInputsLevel2Member 2020-03-31 0000842633 us-gaap:RevolvingCreditFacilityMember trs:CreditAgreementMember 2020-03-31 0000842633 us-gaap:RevolvingCreditFacilityMember trs:CreditAgreementMember 2019-12-31 0000842633 us-gaap:RevolvingCreditFacilityMember trs:CreditAgreementMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0000842633 us-gaap:RevolvingCreditFacilityMember trs:CreditAgreementMember us-gaap:FairValueInputsLevel2Member 2020-03-31 0000842633 us-gaap:RevolvingCreditFacilityMember 2019-12-31 0000842633 trs:A4.875SeniorUnsecuredNotesDue2025Member us-gaap:SeniorNotesMember 2020-01-01 2020-03-31 0000842633 us-gaap:RevolvingCreditFacilityMember 2020-01-01 2020-03-31 0000842633 trs:A4.875SeniorUnsecuredNotesDue2025Member us-gaap:SeniorNotesMember 2020-03-31 0000842633 trs:A4.875SeniorUnsecuredNotesDue2025Member us-gaap:DebtInstrumentRedemptionPeriodOneMember us-gaap:SeniorNotesMember 2020-01-01 2020-03-31 0000842633 trs:RevolvingCreditAndTermLoanFacilitiesMember 2020-03-31 0000842633 us-gaap:RevolvingCreditFacilityMember 2020-03-31 0000842633 us-gaap:LetterOfCreditMember 2020-03-31 0000842633 us-gaap:RevolvingCreditFacilityMember 2020-03-31 0000842633 us-gaap:LetterOfCreditMember 2019-12-31 0000842633 us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-03-31 0000842633 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000842633 srt:MaximumMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000842633 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-03-31 0000842633 srt:MinimumMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000842633 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-03-31 0000842633 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-03-31 0000842633 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000842633 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000842633 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000842633 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000842633 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000842633 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000842633 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000842633 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000842633 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000842633 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000842633 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000842633 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000842633 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000842633 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0000842633 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000842633 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000842633 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2020-03-31 0000842633 us-gaap:OtherAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000842633 us-gaap:OtherAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000842633 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-01-01 2020-03-31 0000842633 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-01-01 2019-03-31 0000842633 us-gaap:AsbestosIssueMember 2020-01-01 2020-03-31 0000842633 us-gaap:AsbestosIssueMember 2019-12-31 0000842633 us-gaap:AsbestosIssueMember 2018-01-01 2018-12-31 0000842633 us-gaap:AsbestosIssueMember 2020-03-31 0000842633 us-gaap:AsbestosIssueMember 2018-12-31 0000842633 us-gaap:AsbestosIssueMember 1991-01-01 2020-03-31 0000842633 trs:PunitiveOnlyDamagesMember us-gaap:PendingLitigationMember us-gaap:AsbestosIssueMember 2020-03-31 0000842633 trs:CompensatoryOnlyDamagesMember us-gaap:PendingLitigationMember us-gaap:AsbestosIssueMember 2020-03-31 0000842633 trs:PunitiveOnlyDamagesMember us-gaap:PendingLitigationMember us-gaap:AsbestosIssueMember 2020-01-01 2020-03-31 0000842633 trs:Range3Member trs:CompensatoryOnlyDamagesMember us-gaap:PendingLitigationMember us-gaap:AsbestosIssueMember 2020-03-31 0000842633 trs:Range1Member trs:CompensatoryOnlyDamagesMember us-gaap:PendingLitigationMember us-gaap:AsbestosIssueMember 2020-03-31 0000842633 trs:Range2Member trs:CompensatoryOnlyDamagesMember us-gaap:PendingLitigationMember us-gaap:AsbestosIssueMember 2020-03-31 0000842633 srt:MinimumMember trs:Range3Member trs:PunitiveOnlyDamagesMember us-gaap:AsbestosIssueMember 2020-01-01 2020-03-31 0000842633 srt:MinimumMember trs:Range1Member trs:PunitiveOnlyDamagesMember us-gaap:AsbestosIssueMember 2020-01-01 2020-03-31 0000842633 srt:MaximumMember trs:Range1Member trs:PunitiveOnlyDamagesMember us-gaap:AsbestosIssueMember 2020-01-01 2020-03-31 0000842633 srt:MaximumMember trs:Range2Member trs:PunitiveOnlyDamagesMember us-gaap:AsbestosIssueMember 2020-01-01 2020-03-31 0000842633 srt:MinimumMember trs:Range2Member trs:PunitiveOnlyDamagesMember us-gaap:AsbestosIssueMember 2020-01-01 2020-03-31 0000842633 srt:MinimumMember trs:Range1Member trs:CompensatoryOnlyDamagesMember us-gaap:AsbestosIssueMember 2020-01-01 2020-03-31 0000842633 srt:MinimumMember trs:Range3Member trs:CompensatoryOnlyDamagesMember us-gaap:AsbestosIssueMember 2020-01-01 2020-03-31 0000842633 srt:MaximumMember trs:Range2Member trs:CompensatoryOnlyDamagesMember us-gaap:AsbestosIssueMember 2020-01-01 2020-03-31 0000842633 srt:MinimumMember trs:Range2Member trs:CompensatoryOnlyDamagesMember us-gaap:AsbestosIssueMember 2020-01-01 2020-03-31 0000842633 srt:MaximumMember trs:Range1Member trs:CompensatoryOnlyDamagesMember us-gaap:AsbestosIssueMember 2020-01-01 2020-03-31 0000842633 srt:MaximumMember trs:Range2Member trs:CompensatoryAndPunitiveDamagesMember us-gaap:AsbestosIssueMember 2020-01-01 2020-03-31 0000842633 srt:MaximumMember trs:Range1Member trs:CompensatoryAndPunitiveDamagesMember us-gaap:AsbestosIssueMember 2020-01-01 2020-03-31 0000842633 srt:MinimumMember trs:Range1Member trs:CompensatoryAndPunitiveDamagesMember us-gaap:AsbestosIssueMember 2020-01-01 2020-03-31 0000842633 srt:MinimumMember trs:Range3Member trs:CompensatoryAndPunitiveDamagesMember us-gaap:AsbestosIssueMember 2020-01-01 2020-03-31 0000842633 srt:MinimumMember trs:Range2Member trs:CompensatoryAndPunitiveDamagesMember us-gaap:AsbestosIssueMember 2020-01-01 2020-03-31 0000842633 us-gaap:OperatingSegmentsMember trs:SpecialtyProductsReportableSegmentMember 2019-01-01 2019-03-31 0000842633 us-gaap:OperatingSegmentsMember trs:PackagingReportableSegmentMember 2020-01-01 2020-03-31 0000842633 us-gaap:OperatingSegmentsMember trs:AerospaceDefenseReportableSegmentMember 2019-01-01 2019-03-31 0000842633 us-gaap:CorporateNonSegmentMember us-gaap:CorporateNonSegmentMember 2019-01-01 2019-03-31 0000842633 us-gaap:OperatingSegmentsMember trs:PackagingReportableSegmentMember 2019-01-01 2019-03-31 0000842633 us-gaap:CorporateNonSegmentMember us-gaap:CorporateNonSegmentMember 2020-01-01 2020-03-31 0000842633 us-gaap:OperatingSegmentsMember trs:AerospaceDefenseReportableSegmentMember 2020-01-01 2020-03-31 0000842633 us-gaap:OperatingSegmentsMember trs:SpecialtyProductsReportableSegmentMember 2020-01-01 2020-03-31 0000842633 srt:MinimumMember trs:TotalshareholderreturnmetricMember us-gaap:RestrictedStockUnitsRSUMember trs:Plan3Member 2020-01-01 2020-03-31 0000842633 trs:TotalshareholderreturnmetricMember us-gaap:RestrictedStockUnitsRSUMember trs:Plan3Member 2019-01-01 2019-12-31 0000842633 srt:MaximumMember trs:AveragestockpriceMember us-gaap:RestrictedStockUnitsRSUMember trs:Plan2Member 2020-01-01 2020-03-31 0000842633 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember trs:Plan5Member 2020-01-01 2020-03-31 0000842633 us-gaap:RestrictedStockUnitsRSUMember trs:Plan2Member 2020-01-01 2020-03-31 0000842633 srt:MinimumMember trs:AveragestockpriceMember us-gaap:RestrictedStockUnitsRSUMember trs:Plan2Member 2020-01-01 2020-03-31 0000842633 us-gaap:RestrictedStockUnitsRSUMember trs:Plan1Member 2020-01-01 2020-03-31 0000842633 srt:MinimumMember trs:TotalshareholderreturnmetricMember us-gaap:RestrictedStockUnitsRSUMember trs:Plan8Member 2020-01-01 2020-03-31 0000842633 us-gaap:EmployeeStockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-03-31 0000842633 srt:MaximumMember trs:TotalshareholderreturnmetricMember us-gaap:RestrictedStockUnitsRSUMember trs:Plan8Member 2020-01-01 2020-03-31 0000842633 us-gaap:RestrictedStockUnitsRSUMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-03-31 0000842633 srt:MaximumMember trs:TotalshareholderreturnmetricMember us-gaap:RestrictedStockUnitsRSUMember trs:Plan3Member 2020-01-01 2020-03-31 0000842633 us-gaap:RestrictedStockUnitsRSUMember trs:Plan8Member 2020-01-01 2020-03-31 0000842633 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-03-31 0000842633 srt:MaximumMember trs:A3YearEpsCagrMetricMember us-gaap:RestrictedStockUnitsRSUMember trs:Plan8Member 2020-01-01 2020-03-31 0000842633 us-gaap:RestrictedStockUnitsRSUMember trs:Plan5Member 2020-01-01 2020-03-31 0000842633 us-gaap:RestrictedStockUnitsRSUMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-03-31 0000842633 us-gaap:EmployeeStockOptionMember 2020-03-31 0000842633 trs:TotalshareholderreturnmetricMember us-gaap:RestrictedStockUnitsRSUMember trs:Plan3Member 2020-01-01 2020-03-31 0000842633 us-gaap:EmployeeStockOptionMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-03-31 0000842633 us-gaap:RestrictedStockUnitsRSUMember 2020-03-31 0000842633 us-gaap:RestrictedStockUnitsRSUMember 2019-12-31 0000842633 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-03-31 0000842633 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-03-31 0000842633 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-03-31 0000842633 trs:A10b51sharerepurchaseprogramMember 2020-03-31 0000842633 trs:A10b51sharerepurchaseprogramMember 2020-01-01 2020-03-31 0000842633 trs:A10b51sharerepurchaseprogramMember 2019-01-01 2019-03-31 0000842633 trs:A10b51sharerepurchaseprogramMember 2015-12-31 0000842633 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-03-31 0000842633 us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-03-31 0000842633 us-gaap:PensionPlansDefinedBenefitMember 2020-03-31 0000842633 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-03-31 0000842633 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-03-31 0000842633 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-03-31 0000842633 trs:AccumulatedNetGainLossfromHedgesAttributabletoParentMember 2019-01-01 2019-03-31 0000842633 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0000842633 trs:AccumulatedNetGainLossfromHedgesAttributabletoParentMember 2018-12-31 0000842633 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0000842633 us-gaap:AccumulatedTranslationAdjustmentMember 2019-03-31 0000842633 trs:AccumulatedNetGainLossfromHedgesAttributabletoParentMember 2019-03-31 0000842633 trs:AccumulatedNetGainLossfromHedgesAttributabletoParentMember 2019-12-31 0000842633 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-03-31 0000842633 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-03-31 0000842633 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000842633 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0000842633 trs:AccumulatedNetGainLossfromHedgesAttributabletoParentMember 2020-03-31 0000842633 trs:AccumulatedNetGainLossfromHedgesAttributabletoParentMember 2020-01-01 2020-03-31 0000842633 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0000842633 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0000842633 trs:RapakMember us-gaap:SubsequentEventMember 2020-04-17 0000842633 trs:RapakMember 2019-01-01 2019-12-31 trs:claimants iso4217:USD xbrli:shares xbrli:shares trs:cases iso4217:USD utreg:Rate xbrli:pure

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
FORM 10-Q
(Mark One)
 
 
 
 
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
 
 
 
For the Quarterly Period Ended
March 31, 2020
Or
 
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
 
 
 
For the Transition Period from                  to                  .
Commission file number 001-10716
TRIMAS CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
 
38-2687639
(State or other jurisdiction of
incorporation or organization)
 
(IRS Employer
Identification No.)
38505 Woodward Avenue, Suite 200
Bloomfield Hills, Michigan 48304
(Address of principal executive offices, including zip code)
(248631-5450
(Registrant's telephone number, including area code)
Title of each class
Trading symbol(s)
Name of exchange on which registered
Common stock, $0.01 par value
TRS
The NASDAQ Global Market LLC
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes     No .
Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes     No .
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 
Accelerated filer
 
 
 
 
 
Non-accelerated filer
 
Smaller reporting company
 
 
 
 
 
 
 
 
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes     No 
As of April 22, 2020, the number of outstanding shares of the Registrant's common stock, $0.01 par value, was 43,409,552 shares.



TriMas Corporation
Index
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


1


Forward-Looking Statements
This report may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 about our financial condition, results of operations and business. These forward-looking statements can be identified by the use of forward-looking words, such as “may,” “could,” “should,” “estimate,” “project,” “forecast,” “intend,” “expect,” “anticipate,” “believe,” “target,” “plan” or other comparable words, or by discussions of strategy that may involve risks and uncertainties.
These forward-looking statements are subject to numerous assumptions, risks and uncertainties which could materially affect our business, financial condition or future results including, but not limited to: the severity and duration of the ongoing corona virus (“COVID-19”) pandemic on our operations, customers and suppliers, as well as related actions taken by governmental authorities and other third parties in response, each of which is uncertain, rapidly changing and difficult to predict; general economic and currency conditions; material and energy costs; risks and uncertainties associated with intangible assets, including goodwill or other intangible asset impairment charges; competitive factors; future trends; our ability to realize our business strategies; our ability to identify attractive acquisition candidates, successfully integrate acquired operations or realize the intended benefits of such acquisitions; information technology and other cyber-related risks; the performance of our subcontractors and suppliers; supply constraints; market demand; intellectual property factors; litigation; government and regulatory actions, including, without limitation, the impact of tariffs, quotas and surcharges; our leverage; liabilities imposed by our debt instruments; labor disputes; changes to fiscal and tax policies; contingent liabilities relating to acquisition activities; the disruption of operations from catastrophic or extraordinary events, including natural disasters or public health crises; the potential impact of Brexit; tax considerations relating to the Cequent spin-off; our future prospects; and other risks that are discussed in Part I, Item 1A, "Risk Factors," in our Annual Report on Form 10-K for the year ended December 31, 2019 and elsewhere in this report. The risks described in our Annual Report on Form 10-K and elsewhere in this report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deemed to be immaterial also may materially adversely affect our business, financial position and results of operations or cash flows.
The cautionary statements set forth above should be considered in connection with any subsequent written or oral forward-looking statements that we or persons acting on our behalf may issue. We caution readers not to place undue reliance on the statements, which speak only as of the date of this report. We do not undertake any obligation to review or confirm analysts' expectations or estimates or to release publicly any revisions to any forward-looking statement to reflect events or circumstances after the date of this report or to reflect the occurrence of unanticipated events, except as required by law.
We disclose important factors that could cause our actual results to differ materially from our expectations implied by our forward-looking statements under Part I, Item 2, "Management's Discussion and Analysis of Financial Condition and Results of Operations," and elsewhere in this report. These cautionary statements qualify all forward-looking statements attributed to us or persons acting on our behalf. When we indicate that an event, condition or circumstance could or would have an adverse effect on us, we mean to include effects upon our business, financial and other conditions, results of operations, prospects and ability to service our debt.

2


PART I. FINANCIAL INFORMATION

Item 1.    Consolidated Financial Statements
TriMas Corporation
Consolidated Balance Sheet
(Dollars in thousands)


 
March 31,
2020

December 31,
2019
Assets
 
(unaudited)
 

Current assets:
 

 

Cash and cash equivalents
 
$
206,110


$
172,470

Receivables, net of reserves of approximately $2.4 million and $2.1 million as of March 31, 2020 and December 31, 2019, respectively
 
122,580


108,860

Inventories
 
140,420


132,660

Prepaid expenses and other current assets
 
16,230


20,050

Total current assets
 
485,340

 
434,040

Property and equipment, net
 
208,440


214,330

Operating lease right-of-use assets
 
29,490

 
27,850

Goodwill
 
375,670


334,640

Other intangibles, net
 
193,260


161,390

Deferred income taxes
 
3,630

 
500

Other assets
 
24,590


19,950

Total assets
 
$
1,320,420

 
$
1,192,700

Liabilities and Shareholders' Equity
 

 

Current liabilities:
 

 

Accounts payable
 
$
59,460


$
72,670

Accrued liabilities
 
39,660


42,020

Operating lease liabilities, current portion
 
5,380

 
5,100

Total current liabilities
 
104,500

 
119,790

Long-term debt, net
 
444,980


294,690

Operating lease liabilities
 
24,440

 
23,100

Deferred income taxes
 
32,820


16,830

Other long-term liabilities
 
38,220


40,810

Total liabilities
 
644,960

 
495,220

Preferred stock, $0.01 par: Authorized 100,000,000 shares;
Issued and outstanding: None
 

 

Common stock, $0.01 par: Authorized 400,000,000 shares;
Issued and outstanding: 43,409,552 shares at March 31, 2020 and 44,562,679 shares at December 31, 2019
 
430

 
450

Paid-in capital
 
751,440

 
782,880

Accumulated deficit
 
(66,730
)
 
(79,850
)
Accumulated other comprehensive loss
 
(9,680
)
 
(6,000
)
Total shareholders' equity
 
675,460

 
697,480

Total liabilities and shareholders' equity
 
$
1,320,420

 
$
1,192,700



The accompanying notes are an integral part of these financial statements.

3


TriMas Corporation
Consolidated Statement of Income
(Unaudited—dollars in thousands, except for per share amounts)

 
 
Three months ended
March 31,
 
 
2020
 
2019
Net sales
 
$
182,790

 
$
173,370

Cost of sales
 
(136,420
)
 
(126,580
)
Gross profit
 
46,370

 
46,790

Selling, general and administrative expenses
 
(26,540
)
 
(26,990
)
Operating profit
 
19,830

 
19,800

Other expense, net:
 
 
 
 
Interest expense
 
(3,580
)
 
(3,440
)
Other expense, net
 
(80
)
 
(570
)
Other expense, net
 
(3,660
)
 
(4,010
)
Income before income tax expense
 
16,170

 
15,790

Income tax expense
 
(3,050
)
 
(1,240
)
Income from continuing operations
 
13,120

 
14,550

Income from discontinued operations, net of tax
 

 
4,540

Net income
 
$
13,120

 
$
19,090

Basic earnings per share:
 
 
 
 
Continuing operations
 
$
0.30

 
$
0.32

Discontinued operations
 

 
0.10

Net income per share
 
$
0.30

 
$
0.42

Weighted average common shares—basic
 
44,201,053

 
45,578,815

Diluted earnings per share:
 
 
 
 
Continuing operations
 
$
0.30

 
$
0.32

Discontinued operations
 

 
0.10

Net income per share
 
$
0.30

 
$
0.42

Weighted average common shares—diluted
 
44,470,472

 
45,992,182



The accompanying notes are an integral part of these financial statements.

4


TriMas Corporation
Consolidated Statement of Comprehensive Income
(Unaudited—dollars in thousands)

 
 
Three months ended
March 31,
 
 
2020
 
2019
Net income
 
$
13,120

 
$
19,090

Other comprehensive income (loss):
 
 
 
 
Defined benefit plans (Note 16)
 
150

 
100

Foreign currency translation
 
(8,260
)
 
700

Derivative instruments (Note 10)
 
4,430

 
2,220

Total other comprehensive income (loss)
 
(3,680
)
 
3,020

Total comprehensive income
 
$
9,440

 
$
22,110



The accompanying notes are an integral part of these financial statements.



5


TriMas Corporation
Consolidated Statement of Cash Flows
(Unaudited—dollars in thousands)
 
 
Three months ended March 31,
 
 
2020
 
2019
Cash Flows from Operating Activities:
 
 
 
 
Net income
 
$
13,120

 
$
19,090

Income from discontinued operations
 

 
4,540

Income from continuing operations
 
13,120

 
14,550

Adjustments to reconcile income from continuing operations to net cash provided by operating activities, net of acquisition impact:
 

 

Loss on dispositions of assets
 
50

 
10

Depreciation
 
6,660

 
5,690

Amortization of intangible assets
 
4,850

 
4,630

Amortization of debt issue costs
 
290

 
280

Deferred income taxes
 
2,570

 
2,210

Non-cash compensation expense
 
1,940

 
1,320

Increase in receivables
 
(10,610
)
 
(4,530
)
Increase in inventories
 
(110
)
 
(420
)
Increase in prepaid expenses and other assets
 
(110
)
 
(860
)
Decrease in accounts payable and accrued liabilities
 
(14,780
)
 
(7,980
)
Other operating activities
 
(470
)
 
150

Net cash provided by operating activities of continuing operations
 
3,400

 
15,050

Net cash used for operating activities of discontinued operations
 

 
(6,970
)
Net cash provided by operating activities, net of acquisition impact
 
3,400

 
8,080

Cash Flows from Investing Activities:
 
 
 
 
Capital expenditures
 
(3,930
)
 
(6,230
)
Acquisition of businesses, net of cash acquired
 
(84,270
)
 
(22,270
)
Net proceeds from disposition of business, property and equipment
 
1,880

 

Net cash used for investing activities of continuing operations
 
(86,320
)
 
(28,500
)
Net cash used for investing activities of discontinued operations
 

 
(410
)
Net cash used for investing activities
 
(86,320
)
 
(28,910
)
Cash Flows from Financing Activities:
 
 
 
 
Proceeds from borrowings on revolving credit facilities
 
198,290

 
26,250

Repayments of borrowings on revolving credit facilities
 
(48,330
)
 
(25,870
)
Shares surrendered upon exercise and vesting of equity awards to cover taxes
 
(1,830
)
 
(2,620
)
Payments to purchase common stock
 
(31,570
)
 
(670
)
Net cash provided by (used for) financing activities of continuing operations
 
116,560

 
(2,910
)
Net cash provided by financing activities of discontinued operations
 

 

Net cash provided by (used for) financing activities
 
116,560

 
(2,910
)
Cash and Cash Equivalents:
 

 

Increase (decrease) for the period
 
33,640

 
(23,740
)
At beginning of period
 
172,470

 
108,150

At end of period
 
$
206,110

 
$
84,410

Supplemental disclosure of cash flow information:
 

 

Cash paid for interest
 
$
370

 
$
300

Cash paid for taxes
 
$
1,850

 
$
1,870



The accompanying notes are an integral part of these financial statements.

6


TriMas Corporation
Consolidated Statement of Shareholders' Equity
Three Months Ended March 31, 2020 and 2019
(Unaudited—dollars in thousands)

 
 
Common
Stock
 
Paid-in
Capital
 
Accumulated
Deficit
 
Accumulated
Other
Comprehensive
Loss
 
Total
Balances, December 31, 2019
 
$
450

 
$
782,880

 
$
(79,850
)
 
$
(6,000
)
 
$
697,480

Net income
 

 

 
13,120

 

 
13,120

Other comprehensive loss
 

 

 

 
(3,680
)
 
(3,680
)
Purchase of common stock
 
(20
)
 
(31,550
)
 

 

 
(31,570
)
Shares surrendered upon exercise and vesting of equity awards to cover taxes
 

 
(1,830
)
 

 

 
(1,830
)
Non-cash compensation expense
 

 
1,940

 

 

 
1,940

Balances, March 31, 2020
 
$
430

 
$
751,440

 
$
(66,730
)
 
$
(9,680
)
 
$
675,460


 
 
Common
Stock
 
Paid-in
Capital
 
Accumulated
Deficit
 
Accumulated
Other
Comprehensive
Loss
 
Total
Balances, December 31, 2018
 
$
460

 
$
816,500

 
$
(179,660
)
 
$
(16,850
)
 
$
620,450

Net income
 

 

 
19,090

 

 
19,090

Other comprehensive income
 

 

 

 
3,020

 
3,020

Purchase of common stock
 

 
(670
)
 

 

 
(670
)
Shares surrendered upon exercise and vesting of equity awards to cover taxes
 

 
(2,620
)
 

 

 
(2,620
)
Non-cash compensation expense
 

 
1,320

 

 

 
1,320

Impact of accounting standards adoption
 

 

 
1,190

 
(1,270
)
 
(80
)
Balances, March 31, 2019
 
$
460

 
$
814,530

 
$
(159,380
)
 
$
(15,100
)
 
$
640,510


The accompanying notes are an integral part of these financial statements.

7


TRIMAS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)


1. Basis of Presentation
TriMas Corporation ("TriMas" or the "Company"), and its consolidated subsidiaries, designs, engineers and manufactures innovative products under leading brand names for customers primarily in the consumer products, aerospace & defense, and industrial markets.
In the first quarter of 2020, TriMas began reporting its machined components operations, located in Stanton, California and Tolleson, Arizona, as part of its Aerospace segment. The operations were previously reported in the Specialty Products segment. The move of these operations into TriMas Aerospace facilitates a more rapid approach to achieving anticipated synergies from the recent RSA Engineered Products ("RSA") acquisition, allowing the Company to better leverage the machining competencies and resources across its aerospace businesses. See Note 13, "Segment Information," for further information on each of the Company's reportable segments.
In addition, on December 20, 2019, the Company completed the sale of its Lamons division (“Lamons”), a transaction entered into with an investment fund sponsored by First Reserve on November 1, 2019. Lamons was sold for approximately $135 million in cash. The financial results of Lamons were previously reported within the Company's Specialty Products segment, and are presented as discontinued operations for all periods presented in the financial statements attached hereto.
The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries and, in the opinion of management, contain all adjustments, including adjustments of a normal and recurring nature, necessary for a fair presentation of financial position and results of operations. The preparation of financial statements also requires management of the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities. Actual results may differ from such estimates and assumptions due to risks and uncertainties, including uncertainty in the current economic environment due to the ongoing outbreak of a new strain of the coronavirus (“COVID-19”). While the full impact of COVID-19 is unknown and cannot be reasonably estimated at this time, the Company has made appropriate accounting estimates based on the facts and circumstances available as of the reporting date. To the extent there are differences between these estimates and actual results, the Company's consolidated financial statements may be materially affected.
Results of operations for interim periods are not necessarily indicative of results for the full year, and certain prior year amounts have been reclassified to conform to current year presentation. The accompanying consolidated financial statements and notes thereto should be read in conjunction with the Company's 2019 Annual Report on Form 10-K.
2. New Accounting Pronouncements
Recently Issued Accounting Pronouncements
In December 2019, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes" ("ASU 2019-12"), which removes specific exceptions to the general principles in Topic 740, simplifies the accounting for income taxes and provides clarification of certain aspects of current guidance. ASU 2019-12 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020, with early adoption permitted. The Company is in the process of assessing the impact of adoption on its consolidated financial statements.
In August 2018, the FASB issued ASU 2018-14, "Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20)" ("ASU 2018-14"), which modifies the disclosure requirements for employers who sponsor defined benefit pension or other postretirement plans. ASU 2018-14 is effective for fiscal years ending after December 15, 2020, with early adoption permitted. ASU 2018-14 is to be applied retrospectively to all periods presented. The Company is in the process of assessing the impact of adoption on its consolidated financial statements.
Recently Adopted Accounting Pronouncements
In January 2017, the FASB issued ASU 2017-04, "Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment" ("ASU 2017-04"), which simplifies the test for goodwill impairment by eliminating the requirement to perform a hypothetical purchase price allocation to measure the amount of goodwill impairment. The Company adopted ASU 2017-04 on January 1, 2020. The adoption of ASU 2017-04 did not have a material impact on the Company's consolidated financial statements.

8


TRIMAS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)

3. Discontinued Operations
On December 20, 2019, the Company completed the sale of Lamons to two wholly-owned subsidiaries of an investment fund sponsored by First Reserve, pursuant to an Asset and Stock Purchase Agreement dated as of November 1, 2019 (the “Purchase Agreement”), for a purchase price of $135 million, subject to certain adjustments as set forth in the Purchase Agreement. The transaction was finalized in the first quarter of 2020 and resulted in a $1.8 million payment to the Company.
The Company's historical results for Lamons are shown in the accompanying consolidated statement of income as a discontinued operation. Results of discontinued operations are summarized as follows (dollars in thousands):
 
 
Three months ended
March 31,
 
 
2019
Net sales
 
$
47,920

Cost of sales
 
(34,890
)
Gross profit
 
13,030

Selling, general and administrative expenses
 
(6,980
)
Operating profit
 
6,050

Other expense, net
 
(110
)
Income from discontinued operations, before income taxes
 
5,940

Income tax expense
 
(1,400
)
Income from discontinued operations, net of tax
 
$
4,540


4. Revenue
The following table presents the Company’s disaggregated net sales by primary market served (dollars in thousands):
 
 
Three months ended March 31,
Customer Markets
 
2020
 
2019
Consumer Products
 
$
76,270

 
$
67,490

Aerospace & Defense
 
48,920

 
45,580

Industrial
 
57,600

 
60,300

Total net sales
 
$
182,790

 
$
173,370


The Company’s Packaging segment earns revenues from the consumer products (comprised of the beauty and personal care, home care, food and beverage, and health, including pharmaceutical and nutraceutical submarkets) and industrial markets. The Aerospace segment earns revenues from the aerospace & defense market (comprised of commercial, regional and business jet and military submarkets). The Specialty Products segment earns revenues from a variety of submarkets within the industrial market.
5. Acquisitions
2020 Acquisitions
On February 27, 2020, the Company acquired RSA Engineered Products, a manufacturer of complex, highly-engineered and proprietary ducting, connectors and related products for air management systems used in aerospace and defense applications, for an aggregate amount of approximately $84.3 million, net of cash acquired, subject to normal course adjustments. The fair value of assets acquired and liabilities assumed included approximately $80.2 million of goodwill and intangible assets, $10.1 million of net working capital, $2.1 million of property and equipment, and $8.7 million of net deferred tax liabilities. RSA, which is reported in the Company's Aerospace segment, is located in Simi Valley, California and historically generated approximately $30 million in annual revenue.

9


TRIMAS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)

In connection with the acquisition of RSA, the Company recorded approximately $0.5 million of non-cash purchase accounting-related expenses during the three months ended March 31, 2020 within cost of sales related to the step-up in value and subsequent sale of inventory.
2019 Acquisitions
In April 2019, the Company acquired Taplast S.p.A. ("Taplast"), a designer and manufacturer of dispensers, closures and containers for the beauty and personal care, home care, and food and beverage packaging markets, for an aggregate amount of approximately $44.7 million, net of cash acquired. With manufacturing locations in both Italy and Slovakia, Taplast serves markets in Europe and North America and historically generated approximately $32 million in annual revenue. Taplast is reported in the Company's Packaging segment.
In January 2019, the Company acquired Plastic Srl, a manufacturer of single-bodied and assembled polymeric caps and closures for use in home care products, for an aggregate amount of approximately $22.4 million, net of cash acquired. Located in Italy, Plastic Srl serves the home care market throughout Italy and other European countries and historically generated approximately $12 million in annual revenue. Plastic Srl is reported in the Company's Packaging segment.
In connection with the acquisition of Plastic Srl, the Company recorded approximately $1.0 million of non-cash purchase accounting-related expenses during the three months ended March 31, 2019, of which approximately $0.9 million was recognized within selling, general and administrative expenses, primarily related to the write-off of the Plastic Srl trade name acquired that will not be used. In addition, approximately $0.1 million was recognized during the three months ended March 31, 2019, within cost of sales related to the step-up in value and subsequent sale of inventory.
6. Goodwill and Other Intangible Assets
The Company assesses goodwill and other intangible assets for impairment on an annual basis as of October 1, and more frequently if there are changes in the business climate or as a result of a triggering event taking place. The Company considered the current and potential future market and economic impacts that may result from the COVID-19 crisis, including its impact on the Company's reporting units, and also assessed the change in its market capitalization during the first quarter of 2020. Based on this review, and after consideration of the historical excess in fair value over carrying value within the Company's reporting units, the Company determined that there was not a triggering event which would require an interim impairment test to be performed.
In the first quarter of 2020, the Company began reporting its machined products operations within the Aerospace segment. These operations were previously reported in the Company's Specialty Products segment. As a result of the reporting structure change, goodwill of approximately $12.7 million was reassigned from the Specialty Products segment to the Aerospace segment.
Changes in the carrying amount of goodwill for the three months ended March 31, 2020 are summarized as follows (dollars in thousands):
 
Packaging
 
Aerospace
 
Specialty Products
 
Total
Balance, December 31, 2019
$
181,650

 
$
133,690

 
$
19,300

 
$
334,640

Goodwill from acquisitions

 
43,260

 

 
43,260

Goodwill reassigned in segment realignment

 
12,740

 
(12,740
)
 

Foreign currency translation and other
(2,230
)
 

 

 
(2,230
)
Balance, March 31, 2020
$
179,420

 
$
189,690

 
$
6,560

 
$
375,670



10


TRIMAS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)

The Company amortizes its other intangible assets over periods ranging from one to 30 years. The gross carrying amounts and accumulated amortization of the Company's other intangibles are summarized below (dollars in thousands):
 
 
As of March 31, 2020
 
As of December 31, 2019
Intangible Category by Useful Life
 
Gross Carrying Amount
 
Accumulated Amortization
 
Gross Carrying Amount
 
Accumulated Amortization
Finite-lived intangible assets:
 

 

 

 

   Customer relationships, 5 – 12 years
 
$
100,000

 
$
(51,740
)
 
$
73,860

 
$
(49,910
)
   Customer relationships, 15 – 25 years
 
122,280

 
(57,620
)
 
122,280

 
(56,010
)
Total customer relationships
 
222,280

 
(109,360
)
 
196,140

 
(105,920
)
   Technology and other, 1 – 15 years
 
54,060

 
(30,480
)
 
52,430

 
(29,790
)
   Technology and other, 17 – 30 years
 
43,300

 
(38,120
)
 
43,300

 
(37,620
)
Total technology and other
 
97,360

 
(68,600
)
 
95,730

 
(67,410
)
Indefinite-lived intangible assets:
 

 

 

 

 Trademark/Trade names
 
51,580

 

 
42,850

 

Total other intangible assets
 
$
371,220

 
$
(177,960
)
 
$
334,720

 
$
(173,330
)

Amortization expense related to intangible assets as included in the accompanying consolidated statement of income is summarized as follows (dollars in thousands):
 
 
Three months ended March 31,
 
 
2020
 
2019
Technology and other, included in cost of sales
 
$
1,210

 
$
1,200

Customer relationships, included in selling, general and administrative expenses
 
3,640

 
3,430

Total amortization expense
 
$
4,850

 
$
4,630


7. Inventories
Inventories consist of the following components (dollars in thousands):
 
 
March 31,
2020
 
December 31,
2019
Finished goods
 
$
72,880

 
$
68,350

Work in process
 
33,930

 
30,560

Raw materials
 
33,610

 
33,750

Total inventories
 
$
140,420

 
$
132,660



11


TRIMAS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)

8. Property and Equipment, Net
Property and equipment consists of the following components (dollars in thousands):
 
 
March 31,
2020
 
December 31,
2019
Land and land improvements
 
$
19,000

 
$
19,110

Buildings
 
84,930

 
84,880

Machinery and equipment
 
323,120

 
326,990

 
 
427,050

 
430,980

Less: Accumulated depreciation
 
218,610

 
216,650

Property and equipment, net
 
$
208,440

 
$
214,330


Depreciation expense as included in the accompanying consolidated statement of income is as follows (dollars in thousands):
 
 
Three months ended March 31,
 
 
2020
 
2019
Depreciation expense, included in cost of sales
 
$
6,360

 
$
5,430

Depreciation expense, included in selling, general and administrative expenses
 
300

 
260

Total depreciation expense
 
$
6,660

 
$
5,690


9. Long-term Debt
The Company's long-term debt consists of the following (dollars in thousands):
 
 
March 31,
2020
 
December 31,
2019
4.875% Senior Notes due October 2025
 
$
300,000

 
$
300,000

Credit Agreement
 
150,000

 

Debt issuance costs
 
(5,020
)
 
(5,310
)
Long-term debt, net
 
$
444,980

 
$
294,690


Senior Notes
In September 2017, the Company issued $300.0 million aggregate principal amount of 4.875% senior notes due October 15, 2025 ("Senior Notes") at par value in a private placement under Rule 144A of the Securities Act of 1933, as amended. The Senior Notes accrue interest at a rate of 4.875% per annum, payable semi-annually in arrears on April 15 and October 15, commencing on April 15, 2018. The payment of principal and interest is jointly and severally guaranteed, on a senior unsecured basis, by certain subsidiaries of the Company (each a "Guarantor" and collectively the "Guarantors"). The Senior Notes are pari passu in right of payment with all existing and future senior indebtedness and subordinated to all existing and future secured indebtedness to the extent of the value of the assets securing such indebtedness.

12


TRIMAS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)

Prior to October 15, 2020, the Company may redeem up to 35% of the principal amount of the Senior Notes at a redemption price of 104.875% of the principal amount, plus accrued and unpaid interest, if any, to the redemption date, with the net cash proceeds of one or more equity offerings provided that each such redemption occurs within 90 days of the date of closing of each such equity offering. In addition, the Company may redeem all or part of the Senior Notes at a redemption price equal to 100% of the principal amount thereof, plus accrued and unpaid interest, if any, to the redemption date, plus a "make whole" premium. On or after October 15, 2020, the Company may redeem all or part of the Senior Notes at the redemption prices (expressed as percentages of principal amount) set forth below, plus accrued and unpaid interest, if any, to the redemption date, if redeemed during the twelve-month period beginning on October 15 of the years indicated below:
Year
 
Percentage
2020
 
102.438
%
2021
 
101.219
%
2022 and thereafter
 
100.000
%

Credit Agreement
The Company is a party to a credit agreement ("Credit Agreement") consisting of a $300.0 million senior secured revolving credit facility, which permits borrowings denominated in specific foreign currencies, subject to a $125.0 million sub limit, matures on September 20, 2022 and is subject to interest at London Interbank Offered Rate ("LIBOR") plus 1.50%. The interest rate spread is based upon the leverage ratio, as defined, as of the most recent determination date.
The Credit Agreement also provides incremental revolving credit facility commitments in an amount not to exceed the greater of $200.0 million and an amount such that, after giving effect to such incremental commitments and the incurrence of any other indebtedness substantially simultaneously with the making of such commitments, the senior secured net leverage ratio, as defined, is no greater than 3.00 to 1.00. The terms and conditions of any incremental revolving credit facility commitments must be no more favorable than the existing credit facility.
The Company's revolving credit facility allows for the issuance of letters of credit, not to exceed $40.0 million in aggregate. At March 31, 2020, the Company had $150.0 million outstanding under its revolving credit facility and had approximately $131.2 million potentially available after giving effect to approximately $18.8 million of letters of credit issued and outstanding. At December 31, 2019, the Company had no amounts outstanding under its revolving credit facility and had approximately $283.9 million potentially available after giving effect to approximately $16.1 million of letters of credit issued and outstanding. The Company's borrowing capacity was not reduced by leverage restrictions contained in the Credit Agreement as of March 31, 2020 and December 31, 2019. In March 2020, the Company drew $150 million on its revolving credit facility to defend against potential uncertainty or liquidity issues in the financial markets as a result of the COVID-19 crisis.
The debt under the Credit Agreement is an obligation of the Company and certain of its domestic subsidiaries and is secured by substantially all of the assets of such parties. Borrowings under the $125.0 million (equivalent) foreign currency sub limit of the $300.0 million senior secured revolving credit facility are secured by a cross-guarantee amongst, and a pledge of the assets of, the foreign subsidiary borrowers that are a party to the agreement.  The Credit Agreement also contains various negative and affirmative covenants and other requirements affecting the Company and its subsidiaries, including the ability, subject to certain exceptions and limitations, to incur debt, liens, mergers, investments, loans, advances, guarantee obligations, acquisitions, assets dispositions, sale-leaseback transactions, hedging agreements, dividends and other restricted payments, transactions with affiliates, restrictive agreements and amendments to charters, bylaws, and other material documents. The terms of the Credit Agreement also require the Company and its restricted subsidiaries to meet certain restrictive financial covenants and ratios computed quarterly, including a maximum total net leverage ratio (total consolidated indebtedness plus outstanding amounts under the accounts receivable securitization facility, less the aggregate amount of certain unrestricted cash and unrestricted permitted investments, as defined, over consolidated EBITDA, as defined), a maximum senior secured net leverage ratio (total consolidated senior secured indebtedness, less the aggregate amount of certain unrestricted cash and unrestricted permitted investments, as defined, over consolidated EBITDA, as defined) and a minimum interest expense coverage ratio (consolidated EBITDA, as defined, over the sum of consolidated cash interest expense, as defined, and preferred dividends, as defined). At March 31, 2020, the Company was in compliance with its financial covenants contained in the Credit Agreement.

13


TRIMAS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)

Fair Value of Debt
The valuations of the Senior Notes and other debt were determined based on Level 2 inputs under the fair value hierarchy, as defined. The carrying amounts and fair values were as follows (dollars in thousands):
 
 
March 31, 2020
 
December 31, 2019
 
 
Carrying Amount
 
Fair Value
 
Carrying Amount
 
Fair Value
Senior Notes
 
$
300,000

 
$
284,470

 
$
300,000

 
$
309,000

Revolving credit facility
 
150,000

 
150,000

 

 


10. Derivative Instruments
Derivatives Designated as Hedging Instruments
In October 2018, the Company entered into cross-currency swap agreements to hedge its net investment in Euro-denominated assets against future volatility in the exchange rate between the U.S. dollar and the Euro. By doing so, the Company synthetically converted a portion of its U.S. dollar-based long-term debt into Euro-denominated long-term debt. The agreements have a five year tenor at notional amounts declining from $125.0 million to $75.0 million over the contract period. Under the terms of the swap agreements, the Company is to receive net interest payments at a fixed rate of approximately 2.9% of the notional amount. At inception, the cross-currency swaps were designated as net investment hedges.
As of March 31, 2020 and December 31, 2019, the fair value carrying amount of the Company's derivative instruments are recorded as follows (dollars in thousands):
 
 
 
 
Asset / (Liability) Derivatives
Derivatives designated as hedging instruments
 
Balance Sheet Caption
 
March 31,
2020
 
December 31,
2019
Net Investment Hedges
 
 
 
 
 
 
Cross-currency swaps
 
Other assets
 
$
10,400

 
$
4,460


The following table summarizes the income recognized in accumulated other comprehensive income (loss) ("AOCI") on derivative contracts designated as hedging instruments as of March 31, 2020 and December 31, 2019, and the amounts reclassified from AOCI into earnings for the three months ended March 31, 2020 and 2019 (dollars in thousands):
 
Amount of Income Recognized
in AOCI on Derivative
(Effective Portion, net of tax)
 
 
 
Amount of Income (Loss) Reclassified
from AOCI into Earnings
 
 
 
 
Three months ended
March 31,
 
As of
March 31,
2020
 
As of December 31, 2019
 
Location of Income (Loss) Reclassified from AOCI into Earnings (Effective Portion)
 
2020
 
2019
Net Investment Hedges
 
 
 
 
 
 
 
 
 
Cross-currency swaps
$
8,660

 
$
4,230

 
Other income (expense), net
 
$

 
$


Over the next 12 months, the Company does not expect to reclassify any pre-tax deferred amounts from AOCI into earnings.

14


TRIMAS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)

Derivatives Not Designated as Hedging Instruments
As of March 31, 2020, the Company was party to foreign currency exchange forward contracts to economically hedge changes in foreign currency rates with notional amounts of approximately $77.3 million. The Company uses foreign exchange contracts to mitigate the risk associated with fluctuations in currency rates impacting cash flows related to certain of its receivables, payables and intercompany transactions denominated in foreign currencies. The foreign exchange contracts primarily mitigate currency exposures between the U.S. dollar and the Euro, British pound and the Chinese yuan, and have various settlement dates through September 2020. These contracts are not designated as hedge instruments; therefore, gains and losses on these contracts are recognized each period directly into the consolidated statement of income.
The following table summarizes the effects of derivatives not designated as hedging instruments on the Company's consolidated statement of income (dollars in thousands):
 
 
 
 
Amount of Loss Recognized in
Earnings on Derivatives
 
 
 
 
Three months ended
March 31,
 
 
Location of Loss
Recognized in
Earnings on Derivatives
 
2020
 
2019
Derivatives not designated as hedging instruments
 
 
 
 
 
 
Foreign exchange contracts
 
Other expense, net
 
$
(70
)
 
$


Fair Value of Derivatives
The fair value of the Company's derivatives are estimated using an income approach based on valuation techniques to convert future amounts to a single, discounted amount. Estimates of the fair value of the Company's cross-currency swaps and foreign exchange contracts use observable inputs such as interest rate yield curves and forward currency exchange rates. Fair value measurements and the fair value hierarchy level for the Company's assets and liabilities measured at fair value on a recurring basis as of March 31, 2020 and December 31, 2019 are shown below (dollars in thousands):  
Description
 
Frequency
 
Asset / (Liability)
 
Quoted Prices in Active Markets for Identical Assets
(Level 1)
 
Significant Other Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
March 31, 2020
 
 
 
 
 
 
 
 
 
 
Cross-currency swaps
 
Recurring
 
$
10,400

 
$

 
$
10,400

 
$

Foreign exchange contracts
 
Recurring
 
$
(790
)
 
$

 
$
(790
)
 
$

December 31, 2019
 
 
 
 
 
 
 
 
 
 
Cross-currency swaps
 
Recurring
 
$
4,460

 
$

 
$
4,460

 
$

Foreign exchange contracts
 
Recurring
 
$
(770
)
 
$

 
$
(770
)
 
$


11. Leases
The Company leases certain equipment and facilities under non-cancelable operating leases. Leases with an initial term of 12 months or less are not recorded on the balance sheet; expense related to these leases is recognized on a straight-line basis over the lease term.

15


TRIMAS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)

The components of lease expense are as follows (dollars in thousands):
 
 
Three Months Ended March 31, 2020
Three Months Ended March 31, 2019
Operating lease cost
 
$
1,650

$
1,520

Short-term, variable and other lease costs
 
310

240

Total lease cost
 
$
1,960

$
1,760


Maturities of lease liabilities are as follows (dollars in thousands):
Year ended December 31,
 
Operating Leases(a)
2020 (excluding the three months ended March 31, 2020)
 
$
5,110

2021
 
6,100

2022
 
5,340

2023
 
4,530

2024
 
3,780

Thereafter
 
10,790

Total lease payments
 
35,650

Less: Imputed interest
 
(5,830
)
Present value of lease liabilities
 
$
29,820

__________________________
(a)  
The maturity table excludes cash flows associated with exited lease facilities. Liabilities for exited lease facilities are included in accrued liabilities and other long-term liabilities in the accompanying consolidated balance sheet.
The weighted-average remaining lease term of the Company's operating leases as of March 31, 2020 is approximately 6.6 years. The weighted-average discount rate as of March 31, 2020 is approximately 4.9%.
Cash paid for amounts included in the measurement of operating lease liabilities was approximately $1.7 million and $1.6 million during the three months ended March 31, 2020 and 2019, respectively, and is included in cash flows provided by operating activities in the consolidated statement of cash flows.
Right-of-use assets obtained in exchange for lease liabilities were approximately $2.9 million, primarily due to the acquisition of RSA, and $0.1 million during the three months ended March 31, 2020 and 2019, respectively.

16


TRIMAS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)

12. Commitments and Contingencies
Asbestos
As of March 31, 2020, the Company was a party to 348 pending cases involving an aggregate of 4,719 claims primarily alleging personal injury from exposure to asbestos containing materials formerly used in gaskets (both encapsulated and otherwise) manufactured or distributed by Lamons and certain other related subsidiaries for use primarily in the petrochemical, refining and exploration industries. The following chart summarizes the number of claims, number of claims filed, number of claims dismissed, number of claims settled, the average settlement amount per claim and the total defense costs, excluding amounts reimbursed under the Company's primary insurance, at the applicable date and for the applicable periods:
 
 
Claims
pending at
beginning of
period
 
Claims filed
during
period
 
Claims
dismissed
during
period
 
Claims
settled
during
period
 
Claims
pending at
end of
period
 
Average
settlement
amount per
claim during
period
 
Total defense
costs during
period
Three Months Ended March 31, 2020
 
4,759

 
54

 
89

 
5

 
4,719

 
$
56,000

 
$
650,000

Fiscal Year Ended December 31, 2019
 
4,820

 
143

 
172

 
32

 
4,759

 
$
16,616

 
$
2,250,000


In addition, the Company acquired various companies to distribute its products that had distributed gaskets of other manufacturers prior to acquisition. The Company believes that many of its pending cases relate to locations at which none of its gaskets were distributed or used.
The Company may be subjected to significant additional asbestos-related claims in the future, the cost of settling cases in which product identification can be made may increase, and the Company may be subjected to further claims in respect of the former activities of its acquired gasket distributors. The Company is unable to make a meaningful statement concerning the monetary claims made in the asbestos cases given that, among other things, claims may be initially made in some jurisdictions without specifying the amount sought or by simply stating the requisite or maximum permissible monetary relief, and may be amended to alter the amount sought. The large majority of claims do not specify the amount sought. Of the 4,719 claims pending at March 31, 2020, 55 set forth specific amounts of damages (other than those stating the statutory minimum or maximum). At March 31, 2020, of the 55 claims that set forth specific amounts, there was one claim seeking more than $5 million for punitive damages. Below is a breakdown of the compensatory damages sought for those claims seeking specific amounts:
 
 
Compensatory
Range of damages sought (dollars in millions)
 
$0.0 to $0.6
 
$0.6 to $5.0
 
$5.0+
Number of claims
 
 
10
 
45

In addition, relatively few of the claims have reached the discovery stage and even fewer claims have gone past the discovery stage.
Total settlement costs (exclusive of defense costs) for all such cases, some of which were filed over 25 years ago, have been approximately $9.7 million. All relief sought in the asbestos cases is monetary in nature. To date, approximately 40% of the Company's costs related to settlement and defense of asbestos litigation have been covered by its primary insurance. Effective February 14, 2006, the Company entered into a coverage-in-place agreement with its first level excess carriers regarding the coverage to be provided to the Company for asbestos-related claims when the primary insurance is exhausted. The coverage-in-place agreement makes asbestos defense costs and indemnity insurance coverage available to the Company that might otherwise be disputed by the carriers and provides a methodology for the administration of such expenses. The Company's primary insurance exhausted in November 2018, and the Company will be solely responsible for defense costs and indemnity payments prior to the commencement of coverage under this agreement, the duration of which would be subject to the scope of damage awards and settlements paid.

17


TRIMAS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)

Based on the settlements made to date and the number of claims dismissed or withdrawn for lack of product identification, the Company believes that the relief sought (when specified) does not bear a reasonable relationship to its potential liability. Based upon the Company's experience to date, including the trend in annual defense and settlement costs incurred to date, and other available information (including the availability of excess insurance), the Company does not believe these cases will have a material adverse effect on its financial position and results of operations or cash flows.
Claims and Litigation
The Company is subject to other claims and litigation in the ordinary course of business, but does not believe that any such claim or litigation will have a material adverse effect on its financial position and results of operations or cash flows.
13. Segment Information
TriMas reports its operations in three reportable segments: Packaging, Aerospace, and Specialty Products. Each of these segments has discrete financial information that is regularly evaluated by TriMas' president and chief executive officer (chief operating decision maker) in determining resource, personnel and capital allocation, as well as assessing strategy and performance. The Company utilizes its proprietary TriMas Business Model as a standardized set of processes to manage and drive results and strategy across its multi-industry businesses.
Within each of the Company's reportable segments, there are no individual products or product families for which reported net sales accounted for more than 10% of the Company's consolidated net sales. See below for more information regarding the types of products and services provided within each reportable segment:
Packaging – The Packaging segment, which consists primarily of the Rieke®, Taplast and Stolz brands, develops and manufactures a broad array of dispensing products (such as foaming pumps, lotion and soap pumps, beverage dispensers, perfume sprayers, nasal sprayers and trigger sprayers), polymeric and steel caps and closures (such as food lids, flip-top closures, child resistance caps, drum closures and flexible spouts), and polymeric jar products for a variety of consumer products submarkets including, but not limited to, beauty and personal care, home care, food and beverage, and health (including pharmaceutical and nutraceutical), as well as the industrial market.
Aerospace – The Aerospace segment, which includes the Monogram Aerospace Fasteners, Allfast Fastening Systems®, Mac Fasteners, RSA Engineered Products and Martinic Engineering brands, develops, qualifies and manufactures highly-engineered, precision fasteners and machined products and assemblies to serve the aerospace and defense market.
Specialty Products – The Specialty Products segment, which includes the Norris Cylinder and Arrow® Engine brands, designs, manufactures and distributes highly-engineered steel cylinders, wellhead engines and compression systems for use within industrial markets.

18


TRIMAS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(unaudited)

Segment activity is as follows (dollars in thousands):
 
 
Three months ended
March 31,
 
 
2020
 
2019
Net Sales
 
 
 
 
Packaging
 
$
100,050

 
$
88,840

Aerospace
 
48,920

 
45,580

Specialty Products
 
33,820

 
38,950

Total
 
$
182,790

 
$
173,370

Operating Profit (Loss)
 
 
 
 
Packaging
 
$
18,280

 
$
17,640

Aerospace
 
5,080

 
5,810

Specialty Products
 
3,430

 
4,700

Corporate
 
(6,960
)
 
(8,350